Alessandro Orro

The information published in this page are entirely managed by ALESSANDRO ORRO who is completely responsible for it.

Alessandro Orro received his Ph.D. degree in electronics and computer engineering in February 2005, after a three-year course at the University of Cagliari, Italy, under the supervision of Professor G. Armano. He is currently working at Italian National Research Council at the Institute of Biomedical Technologies (CNR-ITB). His main research interests are in the field of Bioinformatics; in particular he is investigating multiple alignment algorithms and techniques for protein secondary structure prediction. The underlying techniques and tools, such as genetic algorithms and artificial neural networks, fall into the category of soft computing.

Interest areas:

Bioinformatics


Contacts

Phone: 02 26422608

International Ids

Scopus Author ID: 55931807500

Research products

Orro A.; Uggeri M.; Rusnati M.; Urbinati C.; Pedemonte N.; Pesce E.; Moscatelli M.; Padoan R.; Cichero E.; Fossa P.; D'Ursi P.

In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library

(2021) in European journal of medicinal chemistry
Caccuri F.; D'Ursi P.; Uggeri M.; Bugatti A.; Mazzuca P.; Zani A.; Filippini F.; Salmona M.; Ribatti D.; Slevin M.; Orro A.; Lu W.; Lio P.; Gallo R.C.; Caruso A.

Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin

(2021) in Proceedings of the National Academy of Sciences of the United States of America
Giagulli C.; Caccuri F.; Zorzan S.; Bugatti A.; Zani A.; Filippini F.; Manocha E.; D'Ursi P.; Orro A.; Dolcetti R.; Caruso A.

B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation

(2020) in Cancer gene therapy
Daniele Zarini, Alessandro Sangion, Emanuele Ferri, Enrico Caruso, Sara Zucchi, Alessandro Orro, Ester Papa

Are In silico approaches applicable as a first step for the prediction of e-liquid toxicity in e-cigarettes?

(2020) in Chemical research in toxicology
Rusnati, Marco; D'Ursi, Pasqualina; Pedemonte, Nicoletta; Urbinati, Chiara; Ford, Robert C.; Cichero, Elena; Uggeri, Matteo; Orro, Alessandro; Fossa, Paola

Recent Strategic Advances in CFTR Drug Discovery: An Overview

(2020) in International journal of molecular sciences (Online)
Zampolli, Jessica; Di Canito, Alessandra; Manconi, Andrea; Milanesi, Luciano; Di Gennaro, Patrizia; Orro, Alessandro

Transcriptomic Analysis ofRhodococcus opacusR7 Grown ono-Xylene by RNA-Seq

(2020) in Frontiers in microbiology
Andolfo, Annapaola; Drago, Denise; Cucchiara, Vito; Nocera, Luigi; Mosca, Ettore; Orro, Alessandro; Bellone, Matteo; Montorsi, Francesco; Briganti, Alberto

DEVELOPMENT AND VALIDATION OF A NOVEL EPS-METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER.

(2019) in The Journal of urology
D'Ursi P.; Uggeri M.; Urbinati C.; Millo E.; Paiardi G.; Milanesi L.; Ford R. C.; Clews J.; Meng X.; Bergese P.; Ridolfi A.; Pedemonte N.; Fossa P.; Orro A.; Rusnati M.

Exploitation of a novel biosensor based on the full-length human F508de1-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue

(2019) in Sensors and actuators. B, Chemical (Print)
Bugatti A.; Paiardi G.; Urbinati C.; Chiodelli P.; Orro A.; Uggeri M.; Milanesi L.; Caruso A.; Caccuri F.; D'Ursi P.; Rusnati M.

Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications

(2019) in Scientific reports (Nature Publishing Group)
Zarini, D.; Zucchi, S.; Trampolin, I.; Orro, A.; Ferri, E.

Use of (Q)SAR models to investigate potential CMR properties of e-liquid ingredients

(2019) in Toxicology letters
Visualize all the publications (since 2016)